Results are exhibited in Figure 1, showing increases of both naïve (CD4+CCR7+CD45RA+) and central memory (CM; CD4+CCR7+CD45RA−) T cells in patients with leiomyoma; meanwhile, both effector memory (EM; CD4+CCR7−CD45RA−) and CCR7−CD45RA+ terminally differentiated effector memory (TEMRA) cells were reduced in patients as compared with healthy controls (all P values <0.05). Here, CCR7 is linked to leiomyoma.